2021

April 27-29, 2021 – Virtual Event
CEO Scott Shandler will be presenting at the Neuroimmunology Drug Development Summit

January 26-28, 2021 – Virtual Event
CEO Scott Shandler will be presenting at the Longevity Therapeutics Conference
2020

September 21 – 24, 2020 – Virtual Event
Longevity Biotech will be attending the Biotech In Europe Forum (BEF).

July 15, 2020 – Virtual Event
CEO Scott Shandler will be presenting at the Biomarkers for Alzheimer’s Disease Summit

April 1, 2020 – Philadelphia, PA
Longevity Biotech awarded grant by Department of Defense for ALS

2019





2018


July 16, 2018 – Philadelphia, PA





January 8-11, 2018 – San Francisco, CA
Longevity Biotech will be attending the RESI Healthcare conference. Contact us to schedule a Business Development meeting.


January 2, 2018 – Philadelphia, PA
2017



October 30, 2017 – New York, NY
Longevity Biotech will be attending the annual Michael J. Fox Foundation Parkinson’s Disease meeting in NYC.
Please contact us to schedule a one-on-one meeting.


October 27, 2017 – Philadelphia, PA
Longevity Biotech is pleased to announce funding support from the National Multiple Sclerosis Society to our evaluate lead candidate, LBT-3627, as a potential treatment for MS.




October 19, 2017 – San Francisco, CA
Longevity Biotech will attend the Breakout Labs Annual Unboxing Event, please contact us to schedule a Business Development meeting.









April 6, 2017 – New York, NY
Longevity Biotech will attend the Breakout Labs East Coast Event, please contact us to schedule a Business Development meeting.


February 10, 2017 – Philadelphia, PA
The Hybridtide platform technology is highlighted in an Angewandte Chemie publication: New Modalities for Challenging Targets in Drug Discovery.



February 7, 2017 – Philadelphia, PA
Longevity Biotech and University of Nebraska Medical center announce follow-on funding for the development of LBT-3627 as a novel therapeutic strategy for Parkinson’s disease.


January 10, 2017 – San Francisco, CA
Longevity Biotech is attending the RESI 2017 conference, please contact us to schedule a Business Development meeting.
2016


November 13-16, 2016 – New York, NY
Longevity Biotech is attending the Partnering For Cures conference in NYC. Please contact us to schedule a Business Development meeting.




October 20, 2016 – San Francisco, CA
Longevity Biotech is attending the Breakout Labs Unboxing event. Please contact us to schedule a Business Development meeting.


June 21, 2016 – Omaha, NE & Philadelphia, PA
UNMC & Longevity Biotech publish novel neurodegenerative diagnostic imaging approach for Parkinson’s disease using LBT-3627.




June 6-9, 2016 – San Francisco, CA
Longevity Biotech will participate as part of the Innovation zone




June 6-7, 2016 – Atlanta, GA
Longevity Biotech will attend the NSF Phase II SBIR Conference.


April 6-7, 2016 – Boston, MA
Longevity Biotech Presents at NIO Neurotech Investing and Partnering conference


March 14-15, 2016 – Cambridge, MA
Longevity Biotech Presents at Boulder Peptide Symposium East




March 8th, 2016 – Cambridge, MA
Longevity Biotech Presents at Breakout Labs Portfolio Day


February 5th, 2016 – Philadelphia, PA
Longevity Biotech featured in Philadelphia Business Journal
2015


December 16th, 2015 – Philadelphia, PA
Neuroinflammation Research published in Journal of Neuroscience
Press Release




June 15-18th, 2015 – Philadelphia PRESENTATION Tuesday June 16th @ 3:15pm. Theater 3, “Doctor Nucleus”
Longevity Biotech will be participating at this year’s international BIO conference. Please contact us to schedule 1-on-1 meetings.






March 1st, 2015
Longevity applies innovative platform to CNS biologics.


January 13th, 2015 – San Francisco, California
Longevity Biotech will attend the 2015 Redefining Early Stage Investments conference for privately held biotechnology firms.


January 12-14, 2015 – San Francisco, California
Longevity Biotech will attend the 2015 Biotech Showcase for privately held biotechnology firms.
2014



December 13th-14th, 2014 – Verbier, Switzerland
NetScientific hosts portfolio conference in Verbier




November 20th, 2014 – NY, NY
EpiBone, Longevity Biotech and Modern Meadow to headline Breakout Labs event in NY, NY


November 15-19th, 2014 – Washington, DC
University of Nebraska Medical Center together with Longevity Biotech to present poster at Society for Neuroscience Annual Meeting




October 9th, 2014 – San Francisco, California
Longevity Biotech to attend Breakout Labs Unboxing event in San Francisco, CA


September 22-24th, 2014 – Boulder, Colorado
Longevity Biotech to attend Boulder Peptide Symposium



July 23rd, 2014 – San Francisco, California
NetScientific announces investment in Longevity Biotech



June 25th, 2014 – San Diego, California
CEO Scott Shandler Interviewed at BIO


June 23rd – June 26th, 2014 – San Diego, California
Longevity Biotech Selected to present at BIO 2014 International Convention


April 29, 2014 – Madison, Wisconsin
Chief Scientific Officer Prof. Samuel Gellman elected to the National Academy of Sciences


March 26, 2014 – Washington D.C.
Longevity Biotech receives 2014 Innovation Showcase Award


April 29, 2014 – Madison, Wisconsin
Chief Scientific Officer Prof. Samuel Gellman elected to the National Academy of Sciences


February 21, 2014 – Philadelphia, Pennsylvania
Longevity’s Hybridtides not just ‘me-too’ peptides




January 13-15, 2014 – San Francisco, California
Longevity Biotech will be presenting at the Biotech Showcase 2014 for privately held biotechnology firms on Wednesday January 15th at 9:00am.



January 1, 2014 – Philadelphia, Pennsylvania
Longevity Biotech has been awarded a Phase I SBIR grant from the NSF to further the oral delivery efforts of Hybridtide-based therapeutics.
2013


June 25th, 2013 – Hawaii
Longevity Biotech Chief Scientific Officer wins 2013 Makineni Award




April 21-24, 2013 – Chicago, Illinois
Longevity Biotech will be participating in the 2013 Biotechnology Entrepreneurship Boot Camp and partnering activities


February 25, 2013 – Philadelphia, Pennsylvania
Longevity: Internal Improvements. Longevity stabilizing peptides internally with non-natural beta amino acids.


January 7-9, 2013 – San Francisco, California
Longevity Biotech will be presenting at the Biotech Showcase 2013 for privately held biotechnology firms.
2012




November 13-14th, 2012 – Madison, Wisconsin
Wisconsin Investors Forum


April 17, 2012 – San Francisco, California
Tech visionary Thiel sets out to spark a biotech revolution


October 22, 2012 – Philadelphia, Pennsylvania
Longevity Biotech will be presenting as part of the Company Showcase program at the PA Biotech 2012 conference.
2011


June 21, 2011 – Philadelphia, Pennsylvania
Science Center welcomes five early stage companies in lifesci, investment, and medical device